[Use of 17,21-di-monochloroacetyl-ajmaline in the prevention and therapy of arrhythmia caused by myocardial hyperexcitability].
D000470:Alkaloids / Q000627:therapeutic use*; D001145:Arrhythmias, Cardiac / Q000188:drug therapy*; D001281:Atrial Fibrillation / Q000188:drug therapy; D005117:Cardiac Complexes, Premature / Q000188:drug therapy; D006801:Humans; D011807:Quinolizines / Q000627:therapeutic use*; D013610:Tachycardia / Q000188:drug therapy; D013614:Tachycardia, Paroxysmal / Q000188:drug therapy; D014693:Ventricular Fibrillation / Q000188:drug therapy; D014927:Wolff-Parkinson-White Syndrome / Q000188:drug therapy
D000470:Alkaloids; D011807:Quinolizines
Impiego della 17,21-di-monocloracetil-ajmalina nella profilassi e terapia delle turbe del ritmo da ipereccitabilità miocardica.